Biopolymer nanoparticle production for controlled release of biopharmaceuticals.
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentChitosan: An Update on Potential Biomedical and Pharmaceutical ApplicationsToxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment.In-fiber production of polymeric particles for biosensing and encapsulation.Mutant KRAS is a druggable target for pancreatic cancer.PLGA based drug delivery systems: Promising carriers for wound healing activity.Preparation methods and applications behind alginate-based particles.Separation, antitumor activities, and encapsulation of polypeptide from Chlorella pyrenoidosa.
P2860
Q24597625-03A208DE-B935-4471-BE4C-DFAA6B6354F6Q26796623-5F820D99-578C-44C5-B0F5-BF8425DA347DQ33705431-DC2EE16B-3E51-4B27-80F4-D7BCB5FC5503Q34982558-588C4853-CE84-47D5-B538-FE1BDE9C9530Q37409321-45BA6500-0935-4877-B07F-6E1140B0FC1DQ38691458-8B228C16-B802-4ECD-8548-83DB63E16DC6Q38918979-86A4298A-4D2D-4E26-B6C7-5D01EF99480EQ46312698-578B9654-2353-47B3-AB00-6B065D44A804
P2860
Biopolymer nanoparticle production for controlled release of biopharmaceuticals.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biopolymer nanoparticle production for controlled release of biopharmaceuticals.
@en
type
label
Biopolymer nanoparticle production for controlled release of biopharmaceuticals.
@en
prefLabel
Biopolymer nanoparticle production for controlled release of biopharmaceuticals.
@en
P2860
P1476
Biopolymer nanoparticle production for controlled release of biopharmaceuticals.
@en
P2093
Argyrios Margaritis
David Hudson
P2860
P304
P356
10.3109/07388551.2012.743503
P577
2013-01-07T00:00:00Z